Vivaldi Coelho Rogerio

Director at CRNX; Chief Commercial Officer at Spark Therapeutics, Inc.

Sold, on record
$4.1M
Dollars the filings state
Form 4 sales
6
Latest Jul 2, 2026
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

2
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Spark Therapeutics, Inc.Unusual
    Oct 7, 2015 2015

    Sold 41,000 shares at $48.85 ($2M)

    Vivaldi Coelho Rogerio, Chief Commercial Officer

    Sold 88.4% of holdings ($2.3M position)5,383 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Spark Therapeutics, Inc.Unusual
    Oct 13, 2015 +6 days

    Sold 24,000 shares at $48.15 ($1.2M)

    Vivaldi Coelho Rogerio, Chief Commercial Officer

    Sold 56.2% of holdings ($2.1M position)18,716 shares leftFiling

  3. 3 Form 4 sale Spark Therapeutics, Inc.Unusual
    Apr 21, 2016 +191 days

    Sold 7,000 shares at $40.02 ($280k)

    Vivaldi Coelho Rogerio, Chief Commercial Officer

    Sold 27.2% of holdings ($1M position)18,716 shares leftFiling

  4. 4 Form 4 sale Spark Therapeutics, Inc.Unusual
    Jul 15, 2016 +85 days

    Sold 7,000 shares at $53.03 ($371k)

    Vivaldi Coelho Rogerio, Chief Commercial Officer

    Sold 27.2% of holdings ($1.4M position)18,716 shares left0.3x usual sizeFiling

  5. 5 Form 4 sale CRNXRoutine
    Mar 12, 2026 +3527 days

    Sold 5,000 shares at $36.15 ($181k)

    Vivaldi Coelho Rogerio, Director

    10b5-1 planSold 23.5% of holdings ($770k position)16,300 shares leftFirst sale on recordFiling

  6. 6 Form 4 sale CRNXRoutine
    Jul 2, 2026 +112 days

    Sold 3,000 shares at $40.00 ($120k)

    Vivaldi Coelho Rogerio, Director

    10b5-1 planSold 13.5% of holdings ($889k position)19,225 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (6)

Form 144 notices and Form 4 sales by Vivaldi Coelho Rogerio
Source
Jul 2, 2026Jul 7, 2026CRNXDirectorForm 4 sale3,000$120k13.5%RoutineSEC
Mar 12, 2026Mar 13, 2026CRNXDirectorForm 4 sale5,000$181k23.5%RoutineSEC
Jul 15, 2016Jul 19, 2016Spark Therapeutics, Inc.Chief Commercial OfficerForm 4 sale7,000$371k27.2%UnusualSEC
Apr 21, 2016Apr 22, 2016Spark Therapeutics, Inc.Chief Commercial OfficerForm 4 sale7,000$280k27.2%UnusualSEC
Oct 13, 2015Oct 14, 2015Spark Therapeutics, Inc.Chief Commercial OfficerForm 4 sale24,000$1.2M56.2%UnusualSEC
Oct 7, 2015Oct 9, 2015Spark Therapeutics, Inc.Chief Commercial OfficerForm 4 sale41,000$2M88.4%UnusualSEC